- Previous Close
2,457.00 - Open
2,447.50 - Bid 2,432.00 x --
- Ask 2,438.50 x --
- Day's Range
2,421.00 - 2,465.50 - 52 Week Range
1,905.00 - 2,827.50 - Volume
846,800 - Avg. Volume
881,660 - Market Cap (intraday)
660.594B - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
36.26 - EPS (TTM)
67.08 - Earnings Date May 13, 2025 - May 19, 2025
- Forward Dividend & Yield 44.60 (1.82%)
- Ex-Dividend Date Jun 27, 2025
- 1y Target Est
3,412.00
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. It operates through Medical Business and Device Business segments. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography. In addition, it offers OEM/ODM services for medical devices; and medical and industrial components, such as element wires, stranded conductors, coils, tubes, terminal processing products, and other products. Further, the company develops, manufactures, and sells ultra-fine stainless steel wire ropes, terminal processed products, etc. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was incorporated in 1976 and is headquartered in Aichi, Japan.
www.asahi-intecc.co.jpRecent News: 7747.T
View MorePerformance Overview: 7747.T
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7747.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7747.T
View MoreValuation Measures
Market Cap
667.38B
Enterprise Value
629.39B
Trailing P/E
36.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.82
Price/Book (mrq)
4.22
Enterprise Value/Revenue
5.49
Enterprise Value/EBITDA
17.54
Financial Highlights
Profitability and Income Statement
Profit Margin
15.91%
Return on Assets (ttm)
9.09%
Return on Equity (ttm)
12.30%
Revenue (ttm)
114.7B
Net Income Avi to Common (ttm)
18.25B
Diluted EPS (ttm)
67.08
Balance Sheet and Cash Flow
Total Cash (mrq)
41.56B
Total Debt/Equity (mrq)
2.25%
Levered Free Cash Flow (ttm)
23.37B